Clinical Trials Directory

Trials / Completed

CompletedNCT00798018

Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Sichuan University · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

It has been proven that tracheal tube inflated with lidocaine could decrease the post-intubation sore throat in nitrous oxide anesthesia. In the study, the investigators would like to evaluate the effect of lidocaine inflation in non-nitrous oxide anesthesia and compare the effect of tetracaine, the best mucosal local anesthetics with lidocaine.

Detailed description

The female patients receiving gynecological surgeries were divided into air, saline and 2% lidocaine and 1% tetracaine groups of 25 each using sealed envelope technique. The cuff of the endotracheal tube was inflated by the inflation medium (with the help of intracuff pressure monitoring device) to occlude the leak around the tube by the Minimal Occlusive Volume Technique. This was done by the same anaesthesiologist in all the patients. The cuff volume and pressure were then recorded. The primary outcome of the study was to evaluate the post-intubation sore throat using the visual analogue scale 6h, 24h and 48h after extubation. The secondary outcomes were incidence of complications during emergence of anesthesia and after extubation. Intra-cuff pressure monitoring was done with a pressure monitor, which consisted of the pressure gauge, three-way stopcock whose one end was attached to the pressure monitoring line. Net volume of the inflation medium was noted. Volume of the inflation medium, intra cuff pressure, duration from intubation to extubation and volume of the inflation medium withdrawn from the cuff was noted. Incidence (Yes/No) of tube intolerance, coughing on tube, restlessness, hoarseness, sore throat, breathlessness and laryngospasm were analyzed by the anaesthesiologist who did not know which group the patient belonged to.

Conditions

Interventions

TypeNameDescription
DRUG2% lidocainelidocaine: 2%, injected into the cuff to seal the space between the trachea and the tube at minimal volume
DRUGplaceboAir injected into the cuff to seal the space between the trachea and the tube at minimal volume
DRUG1% tetracainetetracaine: 1%, injected into the cuff to seal the space between the trachea and the tube at minimal volume
DRUGN.S0.9% Normal saline injected into the cuff to seal the space between the trachea and the tube at minimal volume

Timeline

Start date
2008-10-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2008-11-25
Last updated
2009-12-18
Results posted
2009-12-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00798018. Inclusion in this directory is not an endorsement.